NIRSEVIMAB-ALIP vs NITAZOXANIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRSEVIMAB-ALIP vs NITAZOXANIDE: Safety Overview
| Metric | NIRSEVIMAB-ALIP | NITAZOXANIDE |
|---|---|---|
| Total FAERS Reports | 783 | 457 |
| Deaths Reported | 32 | 26 |
| Death Rate | 4.1% | 5.7% |
| Hospitalizations | 281 | 42 |
| Average Patient Age | 3.3 yrs | 47.6 yrs |
| % Female Patients | 46.3% | 57.9% |
| FDA Approval Date | N/A | Apr 15, 2025 |
| Manufacturer | N/A | Rising Pharma Holdings, Inc. |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Discontinued |